ARROWHEAD PHARMACEUTICALS, INC. Derivative, Gain (Loss) on Derivative, Net
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) reported Derivative, Gain (Loss) on Derivative, Net of $0 for the 12-month period ending 2013-09-30, per its 10-K filed 2013-12-18.
Discontinued › Income Statement › Other Income
us-gaap:DerivativeGainLossOnDerivativeNet · last filed 2013-12-18
- ARROWHEAD PHARMACEUTICALS, INC. derivative, gain (loss) on derivative, net for the quarter ending 2012-12-31 was $239.60K.
- ARROWHEAD PHARMACEUTICALS, INC. derivative, gain (loss) on derivative, net for fiscal 2013 was $0.00, a 100.00% decline from fiscal 2012.
- ARROWHEAD PHARMACEUTICALS, INC. derivative, gain (loss) on derivative, net for fiscal 2012 was $85.33K.
| Period end | Derivative, Gain (Loss) on Derivative, Net 3 month | Derivative, Gain (Loss) on Derivative, Net 12 month |
|---|---|---|
| 2013-09-30 | $0.00 10-K · filed 2013-12-18 | |
| 2012-12-31 | $239.60K 10-Q · filed 2013-02-13 | |
| 2012-09-30 | $85.33K 10-K · filed 2012-12-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |